CVS Health Corporation (CVS)

64.98
NYSE
Prev Close 63.86
Day Low/High 63.67 / 65.41
52 Wk Low/High 52.04 / 77.03
Exchange NYSE
Shares Outstanding 1307.09B
Market Cap 83.47B
P/E Ratio 11.57
Div & Yield N.A. (N.A)
Jim Cramer: Why Laggards Like Kohl's, Citi and CVS Can Rise Now

Jim Cramer: Why Laggards Like Kohl's, Citi and CVS Can Rise Now

I am neutral on this market, and only a cool off of the hottest stocks can justify a further advance.

How 'Window Dressing' Can Hide the Losers

How 'Window Dressing' Can Hide the Losers

By selling out of big losers prior to the quarter's close, portfolio managers can hide the stocks from clients, but some downtrodden shares could be ripe for bounces next week, so here's my list.

Future Looks Healthy for CVS

Future Looks Healthy for CVS

CVS and Walgreens Boots Alliance make for good buys.

Real Money Post-Industrial Index Continues to Outperform Major Market Indices

Real Money Post-Industrial Index Continues to Outperform Major Market Indices

Amid May's market turbulence, the RMPIA was buoyed by the more than 4% rise from Medtronic.

3 Managed Care Providers Are Finally Looking Promising on the Charts

3 Managed Care Providers Are Finally Looking Promising on the Charts

A look at the charts and indicators of three big names in the sector .

Make Big Money: Think Like an Insider

Make Big Money: Think Like an Insider

Insider buying by corporate officers should be taken as optimistic visions of the future prospects of their companies and their stock prices.

Jim Cramer: With Biden the Democratic Favorite, These Stocks Are Front-Runners

Jim Cramer: With Biden the Democratic Favorite, These Stocks Are Front-Runners

These managed care stocks can withstand China, politics and a slowdown in the economy.

Real Money Post-Industrial Average Leaves Major Indices in the Dust

Real Money Post-Industrial Average Leaves Major Indices in the Dust

RMPIA outperformed once gain during April.

A Review of the Regulatory Hurdles Remaining for the CVS Aetna Acquisition

A Review of the Regulatory Hurdles Remaining for the CVS Aetna Acquisition

Aetna's additive effects on CVS's earnings might be front and center, but it isn't fully actualized just yet.

'Medicare for All' Efforts Should Rightfully Weigh on CVS Shareholder Minds

'Medicare for All' Efforts Should Rightfully Weigh on CVS Shareholder Minds

As CVS Health's stock continues to run, management's careful approach should be encouraging for beleaguered investors.

Here Are My Trade Ideas for CVS Stock

Here Are My Trade Ideas for CVS Stock

CVS Health is still a cash flow machine.

Fibocall: Early Wednesday Texts

CVS Stock Surges as Aetna Acquisition Comes Into View

CVS Stock Surges as Aetna Acquisition Comes Into View

CVS is setting up an anticipated new stock trajectory for investors.

Context on Fluid Guidance from CVS

3 Top Healthcare Stocks Ripe For the Buying

3 Top Healthcare Stocks Ripe For the Buying

I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.

Chart of the Day: UNH's Universal Healthcare Comments Sting Sector

Chart of the Day: UNH's Universal Healthcare Comments Sting Sector

The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.

UnitedHealth Group Receives Booster Shot From Healthy Earnings, Outlook

UnitedHealth Group Receives Booster Shot From Healthy Earnings, Outlook

The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.

Jim Cramer: When the Death Star Strikes

Jim Cramer: When the Death Star Strikes

It has become almost too onerous to own something that could be in Amazon's crosshairs.

Jim Cramer: Betting That the Next Pieces of News Will Be Very Stock Heartening

Jim Cramer: Betting That the Next Pieces of News Will Be Very Stock Heartening

The consumer is alive, well, and might benefit from a thaw with China and easy to get jobs. So would Boeing and Caterpillar.

Tesla's Debacle and 3 More Stocks to Carefully Watch

Tesla's Debacle and 3 More Stocks to Carefully Watch

Look at the entirety of your portfolio and make sure there are no earnings blow-ups coming from the companies that you own.

Lunch Time Reading

As I sit down to eat some lunch and gather my thoughts for the afternoon, here are some of the items I'll be reading up on:  · Outgoing FDA chief Scott Gottlieb raises 'concern' over Walgreens Boosts Alliance, Inc. , and CVS Health Corp. selling CBD...

Jim Cramer: Lyft Was Cooler Than Being Cool Until It Turned Ice Cold

Jim Cramer: Lyft Was Cooler Than Being Cool Until It Turned Ice Cold

I have had to think long and hard about Lyft, the stock, not the ride-sharing company.

Shift to CBD From Cigarettes Isn't Enough to Sustain Walgreens Stock

Shift to CBD From Cigarettes Isn't Enough to Sustain Walgreens Stock

In fact, the de-emphasizing of cigarettes was blamed for declining same store sales.

Walgreens Market Outlook, ePharmacy Acceleration Pummel Pharmacy Stocks

Walgreens Market Outlook, ePharmacy Acceleration Pummel Pharmacy Stocks

The contagion in pharmacy stocks is spreading and secular trends aren't helping to find a solution anytime soon.

Is Opportunity Knocking as Walgreens Stock Suffers a Bloodletting?

Is Opportunity Knocking as Walgreens Stock Suffers a Bloodletting?

Might this be the bottom? It might.

Walgreens Stock Falls After Earnings, Guidance Disappoint

Walgreens Stock Falls After Earnings, Guidance Disappoint

Walgreens weak guidance is sending shares plummeting on Tuesday.